| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0047 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |